Global Cytology and HPV Testing Industry Research Report, Growth Trends and Competitive Analysis 2023-2029
Description
Global Cytology and HPV Testing Industry Research Report, Growth Trends and Competitive Analysis 2023-2029
Due to the COVID-19 pandemic, the global Cytology and HPV Testing market size was US$ 4,069.01 million in 2022 and is forecast to a readjusted size of US$ 6,753.93 million by 2029 with a CAGR of 7.52% during the forecast period 2023-2029. Fully considering the economic change by this health crisis, Instruments accounting for 34.69% of the Cytology and HPV Testing global market in 2022, is projected to value US$ 2,163.07 million by 2029, growing at a revised 6.41% CAGR from 2023 to 2029. While Hospitals & Clinics segment is altered to a 7.88% CAGR throughout this forecast period.
The global key companies of Cytology and HPV Testing include Thermo Fisher Scientific, Roche Diagnostics, QIAGEN, Bio-rad, Hologic, BD, Hybribio, KingMed Diagnostics, Abbott, bioMérieux, Cepheid, BGI Group, Seegene, Daan Gene, etc. In 2022, the global top five players hold a share approximately 49.18% in terms of revenue.
The United States Cytology and HPV Testing market size was US$ 1,603.55 million in 2022, while China size was US$ 472.93 million. The proportion of the United States was 39.41% in 2022, while China percentage was 11.62%, and it is predicted that China share will reach 13.62% in 2029, trailing a CAGR of 10.04% through the analysis period. As for the Europe Cytology and HPV Testing landscape, Germany is projected to reach US$ 482.74 million by 2029. And in Asia, the notable markets are India and Southeast Asia, CAGR is 10.63% and 9.36% respectively for the next 6-year period.
The market research report offered here is a very useful resource that can help manufacturers, stakeholders, decision-makers, and other market participants to become familiar with every factor impacting the growth of the global Cytology and HPV Testing market. The analysts authoring the report have closely studied key strategies adopted by top players of the global Cytology and HPV Testing market. The report includes SWOT, and other market analyses to provide a clear and deep understanding of important aspects of the global Cytology and HPV Testing market. Readers of the report can become informed about current and future trends of the global Cytology and HPV Testing market and how they will impact market growth during the forecast period.
By Company
Thermo Fisher Scientific
Roche Diagnostics
QIAGEN
Bio-rad
Hologic
BD
Hybribio
KingMed Diagnostics
Abbott
bioMérieux
Cepheid
BGI Group
Seegene
Daan Gene
Segment by Type
Instruments
Consumables
Services
Segment by Application
Hospitals & Clinics
Laboratories
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on.
Chapter 2: Revenue of Cytology and HPV Testing in global and regional level.
Chapter 3: Detailed analysis of Cytology and HPV Testing companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: Asia Pacific by Type, by Application and by region, revenue for each segment.
Chapter 9: Latin America by Type, by Application and by country, revenue for each segment.
Chapter 10: Middle East and Africa, by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Cytology and HPV Testingrevenue, gross margin, and recent development, etc.
Chapter 12: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 13: Research Findings and Conclusion
Due to the COVID-19 pandemic, the global Cytology and HPV Testing market size was US$ 4,069.01 million in 2022 and is forecast to a readjusted size of US$ 6,753.93 million by 2029 with a CAGR of 7.52% during the forecast period 2023-2029. Fully considering the economic change by this health crisis, Instruments accounting for 34.69% of the Cytology and HPV Testing global market in 2022, is projected to value US$ 2,163.07 million by 2029, growing at a revised 6.41% CAGR from 2023 to 2029. While Hospitals & Clinics segment is altered to a 7.88% CAGR throughout this forecast period.
The global key companies of Cytology and HPV Testing include Thermo Fisher Scientific, Roche Diagnostics, QIAGEN, Bio-rad, Hologic, BD, Hybribio, KingMed Diagnostics, Abbott, bioMérieux, Cepheid, BGI Group, Seegene, Daan Gene, etc. In 2022, the global top five players hold a share approximately 49.18% in terms of revenue.
The United States Cytology and HPV Testing market size was US$ 1,603.55 million in 2022, while China size was US$ 472.93 million. The proportion of the United States was 39.41% in 2022, while China percentage was 11.62%, and it is predicted that China share will reach 13.62% in 2029, trailing a CAGR of 10.04% through the analysis period. As for the Europe Cytology and HPV Testing landscape, Germany is projected to reach US$ 482.74 million by 2029. And in Asia, the notable markets are India and Southeast Asia, CAGR is 10.63% and 9.36% respectively for the next 6-year period.
The market research report offered here is a very useful resource that can help manufacturers, stakeholders, decision-makers, and other market participants to become familiar with every factor impacting the growth of the global Cytology and HPV Testing market. The analysts authoring the report have closely studied key strategies adopted by top players of the global Cytology and HPV Testing market. The report includes SWOT, and other market analyses to provide a clear and deep understanding of important aspects of the global Cytology and HPV Testing market. Readers of the report can become informed about current and future trends of the global Cytology and HPV Testing market and how they will impact market growth during the forecast period.
By Company
Thermo Fisher Scientific
Roche Diagnostics
QIAGEN
Bio-rad
Hologic
BD
Hybribio
KingMed Diagnostics
Abbott
bioMérieux
Cepheid
BGI Group
Seegene
Daan Gene
Segment by Type
Instruments
Consumables
Services
Segment by Application
Hospitals & Clinics
Laboratories
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on.
Chapter 2: Revenue of Cytology and HPV Testing in global and regional level.
Chapter 3: Detailed analysis of Cytology and HPV Testing companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: Asia Pacific by Type, by Application and by region, revenue for each segment.
Chapter 9: Latin America by Type, by Application and by country, revenue for each segment.
Chapter 10: Middle East and Africa, by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Cytology and HPV Testingrevenue, gross margin, and recent development, etc.
Chapter 12: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 13: Research Findings and Conclusion
Table of Contents
182 Pages
- 1 Report Overview
- 1.1 Study Scope
- 1.2 Market Analysis By Type
- 1.2.1 Global Cytology And Hpv Testing Market Size Growth Rate By Type: 2018 Vs 2022 Vs 2029
- 1.2.2 Instruments
- 1.2.3 Consumables
- 1.2.4 Services
- 1.3 Market By Application
- 1.3.1 Global Cytology And Hpv Testing Market Growth By Application: 2018 Vs 2022 Vs 2029
- 1.3.2 Hospitals & Clinics
- 1.3.3 Laboratories
- 1.3.4 Others
- 1.4 Assumptions And Limitations
- 1.5 Study Objectives
- 1.6 Years Considered
- 2 Market Perspective
- 2.1 Global Cytology And Hpv Testing Market Size 2018-2029
- 2.2 Cytology And Hpv Testing Market Size Across Key Geographies Worldwide: 2018 Vs 2022 Vs 2029
- 2.3 Global Cytology And Hpv Testing Market Size By Region (2018-2023)
- 2.4 Global Cytology And Hpv Testing Market Size Forecast By Region (2024-2029)
- 2.5 Global Top 10 Cytology And Hpv Testing Countries Ranking By Market Size
- 3 Cytology And Hpv Testing Competition By Company
- 3.1 Global Cytology And Hpv Testing Revenue By Players
- 3.1.1 Global Cytology And Hpv Testing Revenue By Players (2018-2023)
- 3.1.2 Global Cytology And Hpv Testing Market Share By Players (2018-2023)
- 3.2 Global Cytology And Hpv Testing Market Share By Company Type (Tier 1, Tier 2, And Tier 3)
- 3.3 Company Covered: Ranking By Cytology And Hpv Testing Revenue
- 3.4 Global Cytology And Hpv Testing Market Concentration Ratio
- 3.4.1 Global Cytology And Hpv Testing Market Concentration Ratio (Cr5)
- 3.4.2 Global Top 3 And Top 5 Companies By Cytology And Hpv Testing Revenue In 2022
- 3.5 Global Key Players Of Cytology And Hpv Testing Head Office And Area Served
- 3.6 Global Key Players Of Cytology And Hpv Testing, Product Type
- 3.7 Global Key Players Of Cytology And Hpv Testing, Establish Date
- 3.8 Mergers & Acquisitions, Expansion Plans
- 4 Global Cytology And Hpv Testing Breakdown Data By Type
- 4.1 Global Cytology And Hpv Testing Historic Market Size By Type (2018-2023)
- 4.2 Global Cytology And Hpv Testing Forecasted Market Size By Type (2024-2029)
- 5 Global Cytology And Hpv Testing Breakdown Data By Application
- 5.1 Global Cytology And Hpv Testing Historic Market Size By Application (2018-2023)
- 5.2 Global Cytology And Hpv Testing Forecasted Market Size By Application (2024-2029)
- 6 North America
- 6.1 North America Cytology And Hpv Testing Revenue By Company (2018-2023)
- 6.2 North America Cytology And Hpv Testing Revenue By Type (2018-2029)
- 6.3 North America Cytology And Hpv Testing Revenue By Application (2018-2029)
- 6.4 North America Cytology And Hpv Testing Revenue By Country (2018-2029)
- 6.4.1 United States
- 6.4.2 Canada
- 7 Europe
- 7.1 Europe Cytology And Hpv Testing Revenue By Company (2018-2023)
- 7.2 Europe Cytology And Hpv Testing Revenue By Type (2018-2029)
- 7.3 Europe Cytology And Hpv Testing Revenue By Application (2018-2029)
- 7.4 Europe Cytology And Hpv Testing Revenue By Country (2018-2029)
- 7.4.1 Germany
- 7.4.2 France
- 7.4.3 U.K.
- 7.4.4 Italy
- 7.4.5 Russia
- 8 Asia Pacific
- 8.1 Asia Pacific Cytology And Hpv Testing Revenue By Company (2018-2023)
- 8.2 Asia Pacific Cytology And Hpv Testing Revenue By Type (2018-2029)
- 8.3 Asia Pacific Cytology And Hpv Testing Revenue By Application (2018-2029)
- 8.4 Asia Pacific Cytology And Hpv Testing Revenue By Region (2018-2029)
- 8.4.1 China
- 8.4.2 Japan
- 8.4.3 South Korea
- 8.4.4 India
- 8.4.5 Australia
- 8.4.6 Southeast Asia
- 9 Latin America
- 9.1 Latin America Cytology And Hpv Testing Revenue By Company (2018-2023)
- 9.2 Latin America Cytology And Hpv Testing Revenue By Type (2018-2029)
- 9.3 Latin America Cytology And Hpv Testing Revenue By Application (2018-2029)
- 9.4 Latin America Cytology And Hpv Testing Revenue By Country (2018-2029)
- 9.4.1 Mexico
- 9.4.2 Brazil
- 9.4.3 Argentina
- 9.4.4 Colombia
- 10 Middle East And Africa
- 10.1 Middle East And Africa Cytology And Hpv Testing Revenue By Company (2018-2023)
- 10.2 Middle East And Africa Cytology And Hpv Testing Revenue By Type (2018-2029)
- 10.3 Middle East And Africa Cytology And Hpv Testing Revenue By Application (2018-2029)
- 10.4 Middle East And Africa Cytology And Hpv Testing Revenue By Country (2018-2029)
- 10.4.1 Turkey
- 10.4.2 Saudi Arabia
- 10.4.3 Uae
- 11 Company Profiles
- 11.1 Thermo Fisher Scientific
- 11.1.1 Thermo Fisher Scientific Company Details
- 11.1.2 Thermo Fisher Scientific Business Overview
- 11.1.3 Thermo Fisher Scientific Cytology And Hpv Testing Products And Servicess And Services
- 11.1.4 Thermo Fisher Scientific Revenue In Cytology And Hpv Testing Business (2018-2023)
- 11.1.5 Thermo Fisher Scientific Cytology And Hpv Testing Swot Analysis
- 11.2 Roche Diagnostics
- 11.2.1 Roche Diagnostics Company Details
- 11.2.2 Roche Diagnostics Business Overview
- 11.2.3 Roche Diagnostics Cytology And Hpv Testing Products And Servicess And Services
- 11.2.4 Roche Diagnostics Revenue In Cytology And Hpv Testing Business (2018-2023)
- 11.2.5 Roche Diagnostics Cytology And Hpv Testing Swot Analysis
- 11.3 Qiagen
- 11.3.1 Qiagen Company Details
- 11.3.2 Qiagen Business Overview
- 11.3.3 Qiagen Cytology And Hpv Testing Products And Servicess And Services
- 11.3.4 Qiagen Revenue In Cytology And Hpv Testing Business (2018-2023)
- 11.3.5 Qiagen Cytology And Hpv Testing Swot Analysis
- 11.4 Bio-rad
- 11.4.1 Bio-rad Company Details
- 11.4.2 Bio-rad Business Overview
- 11.4.3 Bio-rad Cytology And Hpv Testing Products And Servicess And Services
- 11.4.4 Bio-rad Revenue In Cytology And Hpv Testing Business (2018-2023)
- 11.4.5 Bio-rad Cytology And Hpv Testing Swot Analysis
- 11.5 Hologic
- 11.5.1 Hologic Company Details
- 11.5.2 Hologic Business Overview
- 11.5.3 Hologic Cytology And Hpv Testing Products And Servicess And Services
- 11.5.4 Hologic Revenue In Cytology And Hpv Testing Business (2018-2023)
- 11.5.5 Hologic Cytology And Hpv Testing Swot Analysis
- 11.6 Bd
- 11.6.1 Bd Company Details
- 11.6.2 Bd Business Overview
- 11.6.3 Bd Cytology And Hpv Testing Products And Servicess And Services
- 11.6.4 Bd Revenue In Cytology And Hpv Testing Business (2018-2023)
- 11.6.5 Bd Cytology And Hpv Testing Swot Analysis
- 11.6.6 Bd Recent Development
- 11.7 Hybribio
- 11.7.1 Hybribio Company Details
- 11.7.2 Hybribio Business Overview
- 11.7.3 Hybribio Cytology And Hpv Testing Products And Servicess And Services
- 11.7.4 Hybribio Revenue In Cytology And Hpv Testing Business (2018-2023)
- 11.7.5 Hybribio Cytology And Hpv Testing Swot Analysis
- 11.8 Kingmed Diagnostics
- 11.8.1 Kingmed Diagnostics Company Details
- 11.8.2 Kingmed Diagnostics Business Overview
- 11.8.3 Kingmed Diagnostics Cytology And Hpv Testing Products And Servicess And Services
- 11.8.4 Kingmed Diagnostics Revenue In Cytology And Hpv Testing Business (2018-2023)
- 11.8.5 Kingmed Diagnostics Cytology And Hpv Testing Swot Analysis
- 11.9 Abbott
- 11.9.1 Abbott Company Details
- 11.9.2 Abbott Business Overview
- 11.9.3 Abbott Cytology And Hpv Testing Products And Servicess And Services
- 11.9.4 Abbott Revenue In Cytology And Hpv Testing Business (2018-2023)
- 11.9.5 Abbott Cytology And Hpv Testing Swot Analysis
- 11.9.6 Abbott Recent Development
- 11.10 Biomérieux
- 11.10.1 Biomérieux Company Details
- 11.10.2 Biomérieux Business Overview
- 11.10.3 Biomérieux Cytology And Hpv Testing Products And Servicess And Services
- 11.10.4 Biomérieux Revenue In Cytology And Hpv Testing Business (2018-2023)
- 11.10.5 Biomérieux Cytology And Hpv Testing Swot Analysis
- 11.11 Cepheid
- 11.11.1 Cepheid Company Details
- 11.11.2 Cepheid Business Overview
- 11.11.3 Cepheid Cytology And Hpv Testing Products And Servicess And Services
- 11.11.4 Cepheid Revenue In Cytology And Hpv Testing Business (2018-2023)
- 11.11.5 Cepheid Cytology And Hpv Testing Swot Analysis
- 11.11.6 Cepheid Recent Development
- 11.12 Bgi Group
- 11.12.1 Bgi Group Company Details
- 11.12.2 Bgi Group Business Overview
- 11.12.3 Bgi Group Cytology And Hpv Testing Products And Servicess And Services
- 11.12.4 Bgi Group Revenue In Cytology And Hpv Testing Business (2018-2023)
- 11.12.5 Bgi Group Cytology And Hpv Testing Swot Analysis
- 11.13 Seegene
- 11.13.1 Seegene Company Details
- 11.13.2 Seegene Business Overview
- 11.13.3 Seegene Cytology And Hpv Testing Products And Servicess And Services
- 11.13.4 Seegene Revenue In Cytology And Hpv Testing Business (2018-2023)
- 11.13.5 Seegene Cytology And Hpv Testing Swot Analysis
- 11.14 Daan Gene
- 11.14.1 Daan Gene Company Details
- 11.14.2 Daan Gene Business Overview
- 11.14.3 Daan Gene Cytology And Hpv Testing Products And Servicess And Services
- 11.14.4 Daan Gene Revenue In Cytology And Hpv Testing Business (2018-2023)
- 11.14.5 Daan Gene Cytology And Hpv Testing Swot Analysis
- 12 Cytology And Hpv Testing Market Dynamics
- 12.1 Cytology And Hpv Testing Industry Trends
- 12.2 Cytology And Hpv Testing Market Drivers
- 12.3 Cytology And Hpv Testing Market Challenges
- 12.4 Cytology And Hpv Testing Market Restraints
- 13 Research Findings And Conclusion
- 14 Appendix
- 14.1 Research Methodology
- 14.1.1 Methodology/Research Approach
- 14.1.2 Data Source
- 14.2 Author Details
- 14.3 Disclaimer
- List Of Tables
- Table 1. Global Cytology And Hpv Testing Market Size Growth Rate (Cagr) By Type (Us$ Million): 2018 Vs 2022 Vs 2029
- Table 2. Global Cytology And Hpv Testing Market Size Growth Rate (Cagr) By Application (Us$ Million): 2018 Vs 2022 Vs 2029
- Table 3. Global Cytology And Hpv Testing Market Size (Us$ Million) Growth Rate (Cagr) By Region: 2018 Vs 2022 Vs 2029
- Table 4. Global Cytology And Hpv Testing Revenue By Region (2018-2023) & (Us$ Million)
- Table 5. Global Cytology And Hpv Testing Revenue Forecast By Region (2024-2029) & (Us$ Million)
- Table 6. Global Cytology And Hpv Testing Market Size Of Top 10 Countries, 2018 Vs 2022 Vs 2029, (Us$ Million)
- Table 7. Global Cytology And Hpv Testing Revenue By Players (2018-2023) & (Us$ Million)
- Table 8. Global Cytology And Hpv Testing Market Share By Players (2018-2023)
- Table 9. Global Top Cytology And Hpv Testing Players By Company Type (Tier 1, Tier 2, And Tier 3) & (Based On The Revenue In Cytology And Hpv Testing As Of 2022)
- Table 10. Ranking Of Global Top Cytology And Hpv Testing Companies By Revenue (Us$ Million) In 2022
- Table 11. Global 5 Largest Players Market Share By Cytology And Hpv Testing Revenue (Cr5) & (2018-2023)
- Table 12. Global Key Players Of Cytology And Hpv Testing, Headquarters And Area Served
- Table 13. Global Key Players Of Cytology And Hpv Testing, Product Type
- Table 14. Global Key Players Of Cytology And Hpv Testing, Establish Date
- Table 15. Mergers & Acquisitions, Expansion Plans
- Table 16. Global Cytology And Hpv Testing Market Size By Type (2018-2023) & (Us$ Million)
- Table 17. Global Cytology And Hpv Testing Revenue Market Share By Type (2018-2023)
- Table 18. Global Cytology And Hpv Testing Forecasted Market Size By Type (2024-2029) & (Us$ Million)
- Table 19. Global Cytology And Hpv Testing Revenue Market Share By Type (2024-2029)
- Table 20. Global Cytology And Hpv Testing Market Size By Application (2018-2023) & (Us$ Million)
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
